Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that Sergio Traversa, Chief Executive...

Phosplatin Therapeutics Inc., a clinical stage pharmaceutical company focused on oncology therapeutics, today announced an in-person poster presentation will be given at the American Academy of...

Quell Therapeutics Ltd ("Quell"), a world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, today announced...

IntegriChain, delivering pharma's only comprehensive data, consulting, and business process platform for market access, today announced that Gross-to-Net (GTN) and Life Sciences accounting expert...

Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory...